Antiviral Stockpile Relabeling

The Delaware Department of Health and Social Services, Division of Public Health, is seeking an FDA-registered relabeler/repackager firm to provide comprehensive antiviral stockpile relabeling services for Kent County. The procurement involves relabeling 6,896 courses of Relenza and 15,696 courses of Tamiflu, which have received two-year FDA shelf life extensions. The selected contractor will be responsible for transporting, unpacking, relabeling, repacking, and returning the antivirals while maintaining controlled room temperature between 60-77°F. Key deliverables include detailed tracking methods, loss prevention protocols, and adherence to FDA relabeling guidelines. The evaluation criteria will assess vendor qualifications (30 points), methodology (25 points), scope of services responses (30 points), and proposed costs (15 points). A mandatory pre-bid meeting was held on March 11, 2011, with proposals due by April 7, 2011, at 11:00 AM local time. The initial contract term will expire on July 30, 2011, with potential intermittent renewals not exceeding May 31, 2015.

No specific set-aside designations or restrictions on bidder types were mentioned in the procurement documents. The Department of Health and Social Services reserves the right to award the contract to a bidder other than the lowest cost proposer and may cancel the project based on received proposals. No deposit or performance bond is required for this contract. The procurement documents do not provide specific budget ranges or award values, though funding is confirmed to be available. No incumbent vendor information was disclosed, and there are no apparent requirements for integration with existing infrastructure or technology. The primary requirement is that the relabeling work must be performed at an FDA-registered and approved site, which specifically cannot be the Division of Public Health's current warehouse in McKee Business Park. The total volume of antivirals to be processed is approximately 10 pallets, spanning two different medication types.